Article
Comprehensive profiling of cancer neoantigens from aberrant RNA splicing
1 May 2024
Abstract excerpt
BACKGROUND: Cancer neoantigens arise from protein-altering somatic mutations in tumor and rank among the most promising next-generation immuno-oncology agents when used in combination with immune checkpoint inhibitors. We previously developed a computational framework, REAL-neo, for identification, quality control, and prioritization of both class-I and class-II human leucocyte antigen (HLA)-presented neoantigens...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
